ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
BAUDETTE, Minn., March 2, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Foo... Biopharmaceuticals, Neurology, FDA ANI Pharmaceuticals, Memantine, Alzheimer's
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Alzheimer's | Brain | Marketing | Namenda | Neurology | New Drug Applications | Pharmaceuticals